Last week some members of our team attended the Annual American Academy of Neurology meeting in Philadelphia, PA. It's one of the largest professional meetings of neurologists, and brings attention to the latest innovative science, research, and clinical updates within the field of neurology.
Our Chief Scientist, Dr. Rosalind Picard, spoke about the value that mobile wearables, such as Embrace2, can provide to neurologists and neurology patients, and how they can advance research in neurology.
For example, wearable devices can accurately track seizures so patients have an improved seizure count. Embrace2 stores all of the possible generalized tonic-clonic seizures that have been detected, and allows users to add any other seizures in a companion app, Mate, which serves as a digital seizure diary. Having an accurate account of patients' seizures may help physicians make more informed decisions about treatments.
